Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1206.00

7.05 (0.59%)

< Home < Back

Dr. Reddys Laboratories Ltd. News

>>

Dr Reddys Laboratories informs about press release

>>

Dr. Reddy’s launches Bosutinib Tablets 400mg in US

>>

Dr. Reddy's Laboratories launches generic Semaglutide Injection in Canada

>>

Dr. Reddy’s Laboratories informs about press release

>>

Dr. Reddy's Laboratories reports 86% plunge in Q4FY26 consolidated net profit

>>

Dr. Reddy's Lab - Quaterly Results

>>

Dr. Reddy's Lab gets Health Canada’s nod for Generic Semaglutide Injection

>>

Dr. Reddy’s Laboratories informs about updates

>>

Dr. Reddy’s Laboratories informs about clarification on news item

>>

Dr. Reddy’s Laboratories informs about compliances certificate

<< < 1 2 3 ...144 > >>